Company Filing History:
Years Active: 2007-2012
Title: Athena Spanoyannis: Innovator in Neurotoxin Modifications
Introduction
Athena Spanoyannis is a notable inventor based in Ashburn, VA (US), recognized for her contributions to the field of neurotoxin modifications. With a total of four patents to her name, she has made significant strides in developing innovative solutions for various medical conditions.
Latest Patents
Athena's latest patents focus on post-translational modifications and clostridial neurotoxins. The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
Career Highlights
Athena Spanoyannis is currently associated with Allergan, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on therapeutic applications.
Collaborations
Some of her notable coworkers include Lance Steward and Ester Fernandez-Salas, who contribute to her innovative projects and research initiatives.
Conclusion
Athena Spanoyannis exemplifies the spirit of innovation in the field of neurotoxin research, with her patents paving the way for new treatment options. Her work continues to inspire advancements in medical science.